Cargando…
Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells
Both sorafenib and interleukin-27 (IL-27) are antineoplastic drugs. This study aimed to investigate the synergistic effect of these two drugs on bladder cancer cells. HTB-9 and T24 cells were stimulated with IL-27 (50 ng/mL), sorafenib (2 μM) or the synergistic action of these two drugs. The cells w...
Autores principales: | Cao, J.Y., Yin, H.S., Li, H.S., Yu, X.Q., Han, X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520222/ https://www.ncbi.nlm.nih.gov/pubmed/28746469 http://dx.doi.org/10.1590/1414-431X20176207 |
Ejemplares similares
-
Changes in cardiac aldosterone and its synthase in rats with chronic
heart failure: an intervention study of long-term treatment with recombinant human
brain natriuretic peptide
por: Zhu, X.Q., et al.
Publicado: (2014) -
Long-term, regular remote ischemic preconditioning improves endothelial
function in patients with coronary heart disease
por: Liang, Y., et al.
Publicado: (2015) -
Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells
por: Peng, Hai-Shan, et al.
Publicado: (2014) -
POS-941 THE EFFECTIVENESS OF COVID-19 VACCINE IN REDUCING THE SEVERITY AND MORTALITY RATE AMONG THE END STAGE KIDNEY DISEASE WITH COVID-19
por: FU, M.S., et al.
Publicado: (2022) -
POS-942 Derivation Of Novel Scoring System To Predict Development Of Severe COVID-19 Among End Stage Kidney Disease Patients With Breakthrough Infection After Com-pletion Of SARS-Cov2 Vaccination
por: FU, M.S., et al.
Publicado: (2022)